Forward Citations = 2

Loading Chart...

7 inventors (with patents filed for the assignee):

Marcus F Boehm (12 out of 64 patents)

Esther Martinborough (12 out of 77 patents)

Liming Huang (12 out of 39 patents)

4. Brandon Selfridge (12 out of 12 patents)

5. Marcos Sainz (12 out of 12 patents)

6. Adam Richard Yeager (12 out of 32 patents)

7. Marion Lanier (9 out of 19 patents)

12 patents: Sort by Forward Citations

1. 12384748 - Modulators of mas-related g-protein receptor X2 and related products and methods (2025-08-12),

2. 12275707 - Modulators of mas-related g-protein receptor X2 and related products and methods (2025-04-14),

3. 12240845 - Modulators of mas-related G-protein receptor X2 and related products and methods (2025-03-04),

4. 12129244 - Modulators of Mas-related G-protein receptor X2 and related products and methods (2024-10-29),

5. 12129243 - Modulators of Mas-related G-protein receptor X2 and related products and methods (2024-10-29),

6. 11970452 - Modulators of mas-related G-protein receptor X2 and related products and methods (2024-04-30),

7. 11952346 - Modulators of mas-related G-protein receptor X2 and related products and methods (2024-04-09),

8. 11919864 - Modulators of Mas-related G-protein receptor X2 and related products and methods (2024-03-05),

9. 11840521 - Modulators of Mas-related G-protein receptor X4 and related products and methods (2023-12-12),

10. 11787767 - Modulators of mas-related g-protein receptor X4 and related products and methods (2023-10-17),

11. 11667636 - Modulators of Mas-related G-protein receptor X2 and related products and methods (2023-06-06),

12. 11643399 - Modulators of mas-related G-protein receptor X4 and related products and methods (2023-05-09),

Company Overview

Escient Pharmaceuticals, Inc. is a biopharmaceutical company based in San Diego, California, focused on developing innovative therapies for patients with serious diseases. The company specializes in advancing novel drug candidates that target unmet medical needs, leveraging cutting-edge research in molecular biology and pharmacology. With a commitment to scientific excellence, Escient aims to transform the treatment landscape through its proprietary technologies and collaborative approach to drug development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

12 Patents

#448 in San Diego, CA

#6,061 in California

#25,557 in US

#48,163 in the World

San Diego, CA, United States of America

Escient Pharmaceuticals, Inc.

Forward Citations = 2

7 inventors:

Marcus F Boehm (12 out of 64 patents)

Esther Martinborough (12 out of 77 patents)

Liming Huang (12 out of 39 patents)

4. Brandon Selfridge (12 out of 12 patents)

5. Marcos Sainz (12 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Escient Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/escient-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]